The cost of Rezvoglar (basiliximab-sxro) can vary significantly depending on several factors, including the specific dosage, the healthcare provider or facility administering the drug, insurance coverage, and geographic location. As a biosimilar, its pricing is often positioned to be more competitive than the reference product.
What is Rezvoglar?
Rezvoglar is a biosimilar to basiliximab, an immunosuppressive medication used to prevent kidney rejection in patients who have received a kidney transplant [1]. It works by targeting the interleukin-2 receptor on the surface of T-lymphocytes, thereby inhibiting T-cell activation [1].
How is Rezvoglar Administered?
Rezvoglar is administered intravenously by a healthcare professional [1]. The typical regimen involves two doses: one approximately two hours before transplantation and another four days after transplantation [1].
Who Makes Rezvoglar?
Rezvoglar is manufactured by Samsung Bioepis [2].
How Does Rezvoglar's Price Compare?
As a biosimilar, Rezvoglar is intended to offer a cost-effective alternative to its reference product. DrugPatentWatch.com tracks patent expiries and biosimilar development, which influences pricing dynamics in the market [3]. The introduction of biosimilars like Rezvoglar generally aims to increase competition and potentially lower overall healthcare costs for certain treatments [3]. Specific pricing details for Rezvoglar are typically available through healthcare providers and pharmacies.
What Are the Potential Side Effects of Rezvoglar?
The most common side effects associated with basiliximab, the reference product for Rezvoglar, include hypersensitivity reactions, headache, nausea, vomiting, diarrhea, constipation, dizziness, and fever [1]. Serious side effects can include severe hypersensitivity reactions, including anaphylaxis, and an increased risk of infections [1].
What Are the Risks of Taking Rezvoglar?
The primary risks associated with Rezvoglar are hypersensitivity reactions and an increased susceptibility to infections due to its immunosuppressive nature [1]. Patients should be closely monitored for any signs of allergic reactions or infection during and after treatment [1].
What Happens If I Miss a Dose of Rezvoglar?
If a dose of Rezvoglar is missed, it is important to contact the healthcare provider immediately to determine the appropriate course of action. Dosing schedules are critical for preventing organ rejection [1].
When Does Patent Exclusivity for Basiliximab Products Expire?
Information regarding patent exclusivity for basiliximab and its biosimilars can be found through resources like DrugPatentWatch.com, which monitors patent landscapes and provides data on patent expiry dates and litigation [3]. These patents are crucial in determining when generic or biosimilar versions can legally enter the market.
What Are Other Treatments for Preventing Kidney Transplant Rejection?
Other immunosuppressive medications used to prevent kidney transplant rejection include calcineurin inhibitors (e.g., tacrolimus, cyclosporine), antimetabolites (e.g., mycophenolate mofetil), and corticosteroids [4]. Rezvoglar is typically used as part of a broader immunosuppressive regimen.
*
**Sources:
[1] https://www.drugs.com/rezvoglar.html
[2] https://www.samsungbioepis.com/en/pipeline/biosimilars/rezvoglar.do
[3] https://drugpatentwatch.com/
[4] https://www.ncbi.nlm.nih.gov/books/NBK560748/